Suchergebnisse - "Langer, Jakob"

PubPharm (11)

1

A Network Meta-Analysis Comparing Semaglutide Once-Weekly with Other GLP-1 Receptor Agonists in Japanese Patients with Type 2 Diabetes

enthalten in: Diabetes therapy : research, treatment and education of diabetes and related disorders | 2018

von Webb, N. | Orme, M. | Witkowski, M. | +2

2

A Network Meta-Analysis Comparing Semaglutide Once-Weekly with Other GLP-1 Receptor Agonists in Japanese Patients with Type 2 Diabetes

enthalten in: Diabetes therapy | 2018

von Webb, N. | Orme, M. | Witkowski, M. | +2

3

A Network Meta-Analysis Comparing Semaglutide Once-Weekly with Other GLP-1 Receptor Agonists in Japanese Patients with Type 2 Diabetes

enthalten in: Diabetes therapy | 2018

von Webb, N. | Orme, M. | Witkowski, M. | +2

4

A Network Meta-Analysis Comparing Semaglutide Once-Weekly with Other GLP-1 Receptor Agonists in Japanese Patients with Type 2 Diabetes

enthalten in: Diabetes therapy | 2018

von Webb, N. | Orme, M. | Witkowski, M. | +2

5

Predictors of glycemic control and diabetes-related costs among type 2 diabetes patients initiating therapy with liraglutide in the United States

enthalten in: Journal of medical economics | 2016

von Durden, E. | Lenhart, G. | Lopez-Gonzalez, L. | +2

6

Impact of Medication Adherence and Persistence on Clinical and Economic Outcomes in Patients with Type 2 Diabetes Treated with Liraglutide: A Retrospective Cohort Study

enthalten in: Advances in therapy | 2015

von Buysman, E. | Liu, F. | Hammer, M. | +1

7

Impact of Medication Adherence and Persistence on Clinical and Economic Outcomes in Patients with Type 2 Diabetes Treated with Liraglutide: A Retrospective Cohort Study

enthalten in: Advances in therapy | 2015

von Buysman, E. | Liu, F. | Hammer, M. | +1

8

Impact of Medication Adherence and Persistence on Clinical and Economic Outcomes in Patients with Type 2 Diabetes Treated with Liraglutide: A Retrospective Cohort Study

enthalten in: Advances in therapy | 2015

von Buysman, E. | Liu, F. | Hammer, M. | +1

9

Real-World Cost-Effectiveness: Lower Cost of Treating Patients to Glycemic Goal with Liraglutide versus Exenatide

enthalten in: Advances in therapy | 2014

von DeKoven, M. | Lee, W. | Bouchard, J. | +2

10

Real-World Cost-Effectiveness: Lower Cost of Treating Patients to Glycemic Goal with Liraglutide versus Exenatide

enthalten in: Advances in therapy | 2014

von DeKoven, M. | Lee, W. | Bouchard, J. | +2